Skip to main content

Table 2 Clinical outcomes of patients with pulmonary sclerosing pneumocytoma (N = 61)

From: Pulmonary sclerosing pneumocytoma: clinical features and prognosis

Characteristics Sublobectomy
(n = 36)
Lobectomy
(n = 25)
P value
Surgery time, min 88.17 (26.49) 125.40 (41.64) < 0.001***
Intraoperative blood loss, ml 47.92 (29.36) 79.20 (47.52) 0.006**
Chest tube duration, day 2 (1-7) 3 (2-6) < 0.001***
Postoperative hospital stays, day 4 (2-10) 6 (4-9) 0.003**
Complications, n (%) 2 (5.56) 2 (8) 1.000
Pulmonary infection 0 1 0.410
Prolonged air leak 2 0 0.508
Atelectasis 1 1 1.000
Follow-up time, months 28.5 (7-95) 38.28 (2-92) 0.351
  1. The data was presented as mean (SD) or median (range)
  2. **P < 0.01
  3. ***P < 0.001. Continuous variables were compared using Student’s t test and categorical variables using chi-squared test